Registered stakeholders and individuals have been invited to comment on whether the NICE clinical guideline on OCD and BDD treatment should be updated.
This is a really important opportunity for you to have your say on the guidelines for treatment for OCD and BDD, including: whether the stepped care pathway currently recommended in the guidance needs reconsideration, whether SSRIs are increasingly being used as first-line treatment for young people with OCD and whether paedophilic and violent intrusive thoughts should result in the raising of safeguarding concerns?
Individuals can comment on the surveillance review proposal by filling out the comment form and sending it to Surveillance@nice.org.uk before 5pm on Tuesday, 22 January 2019. It is however, encouraged that you submit your comments through a registered stakeholder organisation, like OCD Action. If you would like to submit your comments to us, please send the comment form to email@example.com by Thursday 17th January.
For more information, please visit the NICE website.